Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$114.22 - $140.1 $5.35 Million - $6.56 Million
46,812 Added 598.01%
54,640 $7.58 Million
Q4 2023

Feb 14, 2024

SELL
$75.49 - $124.16 $528,430 - $869,120
-7,000 Reduced 47.21%
7,828 $971,000
Q3 2023

Nov 14, 2023

BUY
$86.06 - $137.93 $1.28 Million - $2.05 Million
14,828 New
14,828 $1.38 Million
Q1 2023

May 15, 2023

SELL
$104.0 - $122.92 $2.4 Million - $2.83 Million
-23,059 Reduced 23.49%
75,124 $8.73 Million
Q4 2022

Feb 14, 2023

BUY
$84.98 - $122.67 $2.01 Million - $2.91 Million
23,683 Added 31.79%
98,183 $11.1 Million
Q3 2022

Nov 14, 2022

SELL
$76.35 - $94.18 $468,254 - $577,605
-6,133 Reduced 7.61%
74,500 $6 Million
Q2 2022

Aug 15, 2022

BUY
$67.99 - $132.89 $4.17 Million - $8.15 Million
61,303 Added 317.14%
80,633 $6.01 Million
Q1 2022

May 16, 2022

BUY
$94.08 - $130.2 $722,910 - $1 Million
7,684 Added 65.98%
19,330 $9.89 Million
Q4 2021

Feb 14, 2022

BUY
$129.87 - $162.82 $1.45 Million - $1.82 Million
11,160 Added 2296.3%
11,646 $6.25 Million
Q3 2021

Nov 15, 2021

SELL
$106.71 - $143.18 $312,767 - $419,660
-2,931 Reduced 85.78%
486 $266,000
Q2 2021

Aug 16, 2021

BUY
$80.99 - $107.93 $276,742 - $368,796
3,417 New
3,417 $1.46 Million
Q4 2020

Feb 16, 2021

SELL
$78.0 - $104.5 $766,350 - $1.03 Million
-9,825 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$95.51 - $112.95 $938,385 - $1.11 Million
9,825 New
9,825 $4.05 Million
Q4 2018

Feb 14, 2019

SELL
$26.99 - $37.37 $2.18 Million - $3.02 Million
-80,768 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$23.35 - $36.72 $1.89 Million - $2.97 Million
80,768 New
80,768 $11.6 Million
Q2 2018

Aug 03, 2018

SELL
$17.54 - $25.22 $1.66 Million - $2.39 Million
-94,868 Closed
0 $0
Q4 2017

Jan 30, 2018

BUY
$11.12 - $15.38 $1.05 Million - $1.46 Million
94,868
94,868 $5.44 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.